Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Star Bulk Carriers Corp (SBLK) vs GeneDx Holdings Corp (WGS) Price & Performance

Star Bulk Carriers CorpTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Star Bulk Carriers Corp vs GeneDx Holdings Corp — how do they compare? Star Bulk Carriers Corp trades at $27.91 (market cap $3.09B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: Star Bulk Carriers Corp is the larger of the two by market cap, and Star Bulk Carriers Corp pays a 6.79% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

SBLKWGS
Market Cap
$3.09B$2.44B
Sector
IndustrialsTechnology
52-Week High
$29.15$167.51
52-Week Low
$16.79$34.51
Enterprise Value
$3.77B$2.48B
Dividend Yield
6.79%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Star Bulk Carriers Corp

Star Bulk Carriers (SBLK) trades at $27.81, down 2.15% on the day, but maintains a bullish technical outlook with strong support at $27. Fundamentally, the company reported robust Q2 2026 earnings of $1.21 per share, beating estimates, with net income surging to $144.9 million. Revenue growth accelerated to $1.2 billion in 2026, driving a net margin of 23.86%. Recent news highlights the termination of a vessel sale agreement with Diana Shipping, though operations remain unaffected.

The outlook for SBLK is positive, supported by strong profitability, a healthy balance sheet with a debt-to-asset ratio of 27.84%, and a shareholder-friendly dividend policy. Risks include exposure to volatile dry bulk shipping rates and competitive pressures. Analyst consensus is bullish with 58.34% buy ratings, indicating confidence in continued earnings momentum and valuation appeal at a P/E of 10.85.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.

Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.

Returns comparison

Trailing returns across standard periods

About Star Bulk Carriers Corp

Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.

Read more on SBLK

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS